Standout Papers

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessm... 1998 2026 2007 2016 2.0k
  1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. (2000)
    Enzo Bonora, Giovanni Targher et al. Diabetes Care
  2. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease (2010)
    Giovanni Targher, Christopher P. Day et al. New England Journal of Medicine
  3. Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes (2010)
    Anna Zampetaki, Stefan Kiechl et al. Circulation Research
  4. Toll-like Receptor 4 Polymorphisms and Atherogenesis (2002)
    Stefan Kiechl, Eva Lorenz et al. New England Journal of Medicine
  5. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. (1998)
    Enzo Bonora, Stefan Kiechl et al. Diabetes
  6. Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance (1989)
    Ivana Zavaroni, Enzo Bonora et al. New England Journal of Medicine
  7. Estimates ofIn VivoInsulin Action in Man: Comparison of Insulin Tolerance Tests with Euglycemic and Hyperglycemic Glucose Clamp Studies* (1989)
    Enzo Bonora, Paolo Moghetti et al. The Journal of Clinical Endocrinology & Metabolism
  8. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis (2018)
    Alessandro Mantovani, Christopher D. Byrne et al. Diabetes Care

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 86 standout
Sub-graph 1 of 19

Citing Papers

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2023 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout

Works of Enzo Bonora being referenced

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
2021

Author Peers

Author Last Decade Papers Cites
Enzo Bonora 10824 8182 5117 342 24.2k
Amalia Gastaldelli 10660 10395 6357 345 24.5k
Norbert Stefan 7179 9529 5790 333 22.8k
Christopher D. Byrne 10048 16202 4019 494 25.7k
Beverley Balkau 7059 5128 3784 347 19.7k
Karen S.L. Lam 6010 8803 7959 383 25.8k
Weiping Jia 8422 5891 10106 738 27.2k
Robert J. Heine 14784 5359 4550 321 27.8k
Michele Muggeo 7473 4160 3063 212 15.4k
Lynne E. Wagenknecht 7873 4479 3170 333 21.5k
Paresh Dandona 8323 5975 5104 493 24.5k

All Works

Loading papers...

Rankless by CCL
2026